Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Moleculin Biotech at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Moleculin Biotech at ASH 2026 in New Orleans: Booth 249.

OrganizationASH 2026 Attendance
Biotech
Clinical-stage drug developer whose lead program, annamycin, is a next-generation anthracycline built to limit drug resistance and heart toxicity.
Booth
Exhibiting at Booth 249
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Moleculin Biotech

Tell us what you sell and we’ll find the people at Moleculin Biotech most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction